
    
      The purpose of this study is to compare and evaluate the effects of LDL-C and Triglyceride
      (TG) control on the first dose Ezetimibe/Statin (Rosuvastatin 5 mg/Ezetimibe 10 mg)
      combination therapy compared to the average dose Statin (Rosuvastatin 10 mg) monotherapy in
      patients with Type 2 diabetes with hypertriglyceridemia (TG > 200 mg/dL).
    
  